Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion type Assertion NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_head.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion evidence source_evidence_literature NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion SIO_000772 17342071 NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion wasDerivedFrom lhgdn-20090331 NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.
- NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_assertion wasGeneratedBy ECO_0000203 NP223255.RAVpTtRUIJha2N0lk606Fa1vBFjZXvryoBLKCkJIQ55Wg130_provenance.